Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
FDA.gov (2026) 13
This article is intended for general informational purposes only and is not a substitute for medical advice, diagnosis or treatment
Geographic vastness previously restricted Montana access to specialized obesity medicine concentrated in distant metropolitan hospitals
Morgan Research projected that total GLP-1 users in the U.S
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
